Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Aug;5(4):269-275.
doi: 10.1016/j.jpha.2015.05.004. Epub 2015 May 23.

Simultaneous quantitation of folic acid and 5-methyltetrahydrofolic acid in human plasma by HPLC-MS/MS and its application to a pharmacokinetic study

Affiliations

Simultaneous quantitation of folic acid and 5-methyltetrahydrofolic acid in human plasma by HPLC-MS/MS and its application to a pharmacokinetic study

Xiao-Hong Zheng et al. J Pharm Anal. 2015 Aug.

Abstract

A sensitive method based on high-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) has been developed for the simultaneous determination of folic acid (FA) and its active metabolite, 5-methyltetrahydrofolic acid (5-M-THF), in human plasma. The analytes were extracted from plasma with methanol solution containing 10 mg/mL of 2-mercaptoethanol and 0.025% (v/v) ammonium hydroxide. FA and 5-M-THF were more stable after the addition of 2-mercaptoethanol and ammonium hydroxide in the sample preparation procedures of this study than they were in the previously published methods. Chromatographic separation was performed on a Hedera ODS-2 column using a gradient elution system of acetonitrile and 1 mM ammonium acetate buffer solution containing 0.6% formic acid as mobile phase. LC-MS/MS was carried out with an ESI ion-source and operated in the multiple reaction monitoring (MRM) mode. The assay was linear over the concentration ranges of 0.249-19.9 ng/mL for FA, and 5.05-50.5 ng/mL for 5-M-THF. The developed LC-MS/MS method offers increased sensitivity for quantification of FA and 5-M-THF in human plasma and was applicable to a pharmacokinetic study of FA and 5-M-THF.

Keywords: 2-Mercaptoethanol; 5-Methyltetrahydrofolic acid; Folic acid; LC–MS/MS; Pharmacokinetics.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Chemical structures of (A) FA, (B) 5-M-THF and (C) IS and their proposed fragmentation patterns.
Fig. 2
Fig. 2
The degradation of (A) FA (9.95 ng/mL) and (B) 5-M-THF (20.2 ng/mL) in plasma at different concentration levels of 2-mercaptoethanol at room temperature.
Fig. 3
Fig. 3
Typical chromatograms of (A) blank plasma; (B) LLOQ for FA (0.249 ng/mL), 5-M-THF (5.05 ng/mL) and IS in plasma; and (C) plasma obtained from a volunteer at 1.5 h after an oral administration of 0.8 mg folic acid.
Fig. 4
Fig. 4
Mean plasma concentration-time profiles (mean±SD, baseline values corrected) of FA and 5-M-THF in human plasma after an oral administration of 0.8 mg ofb folic acid (n=20).

Similar articles

Cited by

References

    1. Wang X.W., Zhang T., Zhao X. Quantification of folate metabolites in serum using ultra-performance liquid chromatography tandem mass spectrometry. J. Chromatogr. B. 2014;962:9–13. - PubMed
    1. Centers for Disease Control Use of folic acid for prevention of spina bifida and other neural tube defects – 1983–1991. MMVR Morb. Mortal. Wkly. Rep. 1991;40:513–516. - PubMed
    1. American Academy of Pediatrics Committee on Genetics Folic acid for the prevention of neural tube defects. Pediatrics. 1993;92:493–494. - PubMed
    1. Morrison H.I., Schaubel D., Desmeurles M. Serum folate and risk of fatal coronary heart disease. J. Am. Med. Assoc. 1996;275:1893–1896. - PubMed
    1. Giles W.H., Kittner S.J., Croft J.B. Serum folate and risk for coronary heart disease: results from a cohort of US adults. Ann. Epidemiol. 1998;8:490–496. - PubMed